Coherus Biosciences Inc (NASDAQ: CHRS) is -19.57% lower on its value in year-to-date trading and has touched a low of $0.66 and a high of $2.87 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CHRS stock was last observed hovering at around $1.16 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $1.11, the stock is -21.28% and -19.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.9 million and changing -4.31% at the moment leaves the stock -23.67% off its SMA200. CHRS registered -53.16% loss for a year compared to 6-month loss of -35.47%. The firm has a 50-day simple moving average (SMA 50) of $1.37026 and a 200-day simple moving average (SMA200) of $1.46092.
The stock witnessed a -24.49% gain in the last 1 month and extending the period to 3 months gives it a 39.78%, and is -15.91% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.17% over the week and 9.65% over the month.
Coherus Biosciences Inc (CHRS) has around 306 employees, a market worth around $128.33M and $304.34M in sales. Profit margin for the company is -0.15%. Distance from 52-week low is 68.11% and -61.32% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.22%).
with sales reaching $43.88M over the same period.The EPS is expected to grow by 113.96% this year, but quarterly earnings will post -0.65% year-over-year. Quarterly sales are estimated to shrink -52.06% in year-over-year returns.
Coherus Biosciences Inc (CHRS) Top Institutional Holders
175.0 institutions hold shares in Coherus Biosciences Inc (CHRS), with institutional investors hold 70.52% of the company’s shares. The shares outstanding are 115.21M, and float is at 110.99M with Short Float at 26.84%. Institutions hold 69.55% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 11.75 million shares valued at $20.33 million. The investor’s holdings represent 10.4236% of the CHRS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.6 million shares valued at $18.34 million to account for 9.4035 of the shares outstanding. The other top investors are RUBRIC CAPITAL MANAGEMENT LP which holds 10.4 million shares representing 9.224% and valued at over $17.99 million, while TEMASEK HOLDINGS (PRIVATE) LTD holds 5.1608 of the shares totaling 5.82 million with a market value of $10.07 million.
Coherus Biosciences Inc (CHRS) Insider Activity
#####
